Anavex’s experimental drug fails Rett syndrome study, stock falls
Anavex Life Sciences, a biotech company that has come under fire for trying to spin its clinical trial results …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
